{"url_path":"/sec/staa/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000023-index.html","accession_number":"0000718937-26-000023","cik":"0000718937","ticker":"STAA","issuer_name":"STAAR SURGICAL CO","edgar_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000023-index.html","primary_entity_key":"0000718937","primary_entity_name":"STAAR SURGICAL CO"},"word_count":76,"has_tables":true,"body_markdown":"## ITEM 5. OTHER INFORMATION\n\n(c)\nTrading Plans\n\nDuring the quarter ended April 3, 2026, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated:\n\n(i)\nAny contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c); and\n\n(ii)\nAny “non-Rule 10b5-1 trading arrangement” as defined in paragraph (c) of item 408(a) of Regulation S-K.\n\n25"}